• About Us
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Focus Areas
    • Collaborations
  • Our Science
    • Our Pipeline
    • QLS-111
    • Publications & Posters
  • News and Events
  • Careers
  • Contact Us
  • Skip to main content
Qlaris Bio

Qlaris Bio

Careers Contact Us
Archives for Publications and Posters

Publications & Posters

VIEW:

  • All
  • Publications
  • Posters

The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.

2025 World Glaucoma Congress

Safety, tolerability, and ocular hypotensive efficacy of QLS-111, a novel ATP-sensitive potassium channel opener added to latanoprost monotherapy – QC-111-203 “Apteryx” Clinical Study

June 25, 2025

View Poster

Glaucoma Physician

Targeting Episcleral Venous Pressure to Reduce IOP

March 15, 2025

Read Publication

Glaucoma Physician

New Developments in Medical Therapy

March 1, 2025

Read Publication

Investigative Ophthalmology & Visual Science

Relationship Between Diurnal Variations of Episcleral Venous Pressure and Intraocular Pressure

January 1, 2025

Read Publication

2024 TM Society Meeting

CKLP1 to QLS-111: The long winding road from innovation to patient care

October 1, 2024

View Poster

Glaucoma Today

Distal Outflow And Episcleral Venous Pressure

October 28, 2023

Read Publication
  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Qlaris Bio, Inc. © 2025 All Rights Reserved Privacy Policy | Terms of Use | Accessibility Statement

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.